TEVA 7389 (Risedronate sodium 35 mg)
This pill with imprint "TEVA 7389" is Orange, Round and has been identified as Risedronate sodium 35 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Risedronate is used in the treatment of prevention of osteoporosis; paget's disease; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about risedronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 24 Reviews – Add your own review/rating
- Drug class: bisphosphonates
Related treatment guides
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.